強迫性障害治療の世界市場（～2026年）

• 英文タイトル：Global Obsessive-Compulsive Disorder Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04031
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は強迫性障害治療のグローバル市場について調査・分析したレポートです。種類別（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別強迫性障害治療の競争状況、市場シェア
・世界の強迫性障害治療市場：種類別市場規模 2015年-2020年（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）
・世界の強迫性障害治療市場：種類別市場規模予測 2021年-2026年（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）
・世界の強迫性障害治療市場：用途別市場規模 2015年-2020年（クリニック、病院、研究センター）
・世界の強迫性障害治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、研究センター）
・北米の強迫性障害治療市場分析：米国、カナダ
・ヨーロッパの強迫性障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの強迫性障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の強迫性障害治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの強迫性障害治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AbbVie Inc.、Addex Therapeutics Ltd、C4X Discovery Limited、F. Hoffmann-La Roche Ltd.、Novartis AG、Omeros Corporation、Rottapharm SpA、Sellas Inc.
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Obsessive-Compulsive Disorder Treatment Market
The global Obsessive-Compulsive Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Obsessive-Compulsive Disorder Treatment Scope and Market Size
Obsessive-Compulsive Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obsessive-Compulsive Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie Inc.
Addex Therapeutics Ltd
C4X Discovery Limited
F. Hoffmann-La Roche Ltd.
Novartis AG
Omeros Corporation
Rottapharm SpA
Sellas Inc.

Market segment by Type, the product can be split into
ADX-88178
Bitopertin
CR-5542
Dipraglurant IR
Fluvoxamine Maleate
Mavoglurant
Others
Market segment by Application, split into
Clinic
Hospital
Research Center

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obsessive-Compulsive Disorder Treatment Revenue
1.4 Market by Type
1.4.1 Global Obsessive-Compulsive Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ADX-88178
1.4.3 Bitopertin
1.4.4 CR-5542
1.4.5 Dipraglurant IR
1.4.6 Fluvoxamine Maleate
1.4.7 Mavoglurant
1.4.8 Others
1.5 Market by Application
1.5.1 Global Obsessive-Compulsive Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Research Center
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Obsessive-Compulsive Disorder Treatment Market Perspective (2015-2026)
2.2 Global Obsessive-Compulsive Disorder Treatment Growth Trends by Regions
2.2.1 Obsessive-Compulsive Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Obsessive-Compulsive Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Obsessive-Compulsive Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Obsessive-Compulsive Disorder Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Obsessive-Compulsive Disorder Treatment Players by Market Size
3.1.1 Global Top Obsessive-Compulsive Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Obsessive-Compulsive Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obsessive-Compulsive Disorder Treatment Market Concentration Ratio
3.2.1 Global Obsessive-Compulsive Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Obsessive-Compulsive Disorder Treatment Revenue in 2019
3.3 Obsessive-Compulsive Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Obsessive-Compulsive Disorder Treatment Product Solution and Service
3.5 Date of Enter into Obsessive-Compulsive Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Obsessive-Compulsive Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
6.2 Obsessive-Compulsive Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
7.2 Obsessive-Compulsive Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

8 China
8.1 China Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
8.2 Obsessive-Compulsive Disorder Treatment Key Players in China (2019-2020)
8.3 China Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
8.4 China Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
9.2 Obsessive-Compulsive Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
10.2 Obsessive-Compulsive Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

11 India
11.1 India Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
11.2 Obsessive-Compulsive Disorder Treatment Key Players in India (2019-2020)
11.3 India Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
11.4 India Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
12.2 Obsessive-Compulsive Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Details
13.1.2 AbbVie Inc. Business Overview
13.1.3 AbbVie Inc. Obsessive-Compulsive Disorder Treatment Introduction
13.1.4 AbbVie Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020))
13.1.5 AbbVie Inc. Recent Development
13.2 Addex Therapeutics Ltd
13.2.1 Addex Therapeutics Ltd Company Details
13.2.2 Addex Therapeutics Ltd Business Overview
13.2.3 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Introduction
13.2.4 Addex Therapeutics Ltd Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.2.5 Addex Therapeutics Ltd Recent Development
13.3 C4X Discovery Limited
13.3.1 C4X Discovery Limited Company Details
13.3.2 C4X Discovery Limited Business Overview
13.3.3 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Introduction
13.3.4 C4X Discovery Limited Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.3.5 C4X Discovery Limited Recent Development
13.4 F. Hoffmann-La Roche Ltd.
13.4.1 F. Hoffmann-La Roche Ltd. Company Details
13.4.2 F. Hoffmann-La Roche Ltd. Business Overview
13.4.3 F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Introduction
13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
13.5 Novartis AG
13.5.1 Novartis AG Company Details
13.5.2 Novartis AG Business Overview
13.5.3 Novartis AG Obsessive-Compulsive Disorder Treatment Introduction
13.5.4 Novartis AG Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.5.5 Novartis AG Recent Development
13.6 Omeros Corporation
13.6.1 Omeros Corporation Company Details
13.6.2 Omeros Corporation Business Overview
13.6.3 Omeros Corporation Obsessive-Compulsive Disorder Treatment Introduction
13.6.4 Omeros Corporation Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.6.5 Omeros Corporation Recent Development
13.7 Rottapharm SpA
13.7.1 Rottapharm SpA Company Details
13.7.2 Rottapharm SpA Business Overview
13.7.3 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Introduction
13.7.4 Rottapharm SpA Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.7.5 Rottapharm SpA Recent Development
13.8 Sellas Inc.
13.8.1 Sellas Inc. Company Details
13.8.2 Sellas Inc. Business Overview
13.8.3 Sellas Inc. Obsessive-Compulsive Disorder Treatment Introduction
13.8.4 Sellas Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
13.8.5 Sellas Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Obsessive-Compulsive Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Obsessive-Compulsive Disorder Treatment Revenue
Table 3. Ranking of Global Top Obsessive-Compulsive Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Obsessive-Compulsive Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ADX-88178
Table 6. Key Players of Bitopertin
Table 7. Key Players of CR-5542
Table 8. Key Players of Dipraglurant IR
Table 9. Key Players of Fluvoxamine Maleate
Table 10. Key Players of Mavoglurant
Table 11. Key Players of Others
Table 12. Global Obsessive-Compulsive Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Obsessive-Compulsive Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Obsessive-Compulsive Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Obsessive-Compulsive Disorder Treatment Market Share by Regions (2015-2020)
Table 16. Global Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Obsessive-Compulsive Disorder Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Obsessive-Compulsive Disorder Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Obsessive-Compulsive Disorder Treatment Players
Table 23. Global Obsessive-Compulsive Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Obsessive-Compulsive Disorder Treatment Market Share by Players (2015-2020)
Table 25. Global Top Obsessive-Compulsive Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Treatment as of 2019)
Table 26. Global Obsessive-Compulsive Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Obsessive-Compulsive Disorder Treatment Product Solution and Service
Table 29. Date of Enter into Obsessive-Compulsive Disorder Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Obsessive-Compulsive Disorder Treatment Market Size Share by Type (2015-2020)
Table 33. Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Obsessive-Compulsive Disorder Treatment Market Size Share by Application (2015-2020)
Table 35. Global Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Obsessive-Compulsive Disorder Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 39. North America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 41. North America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 45. Europe Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 47. Europe Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 51. China Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 53. China Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 57. Japan Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 59. Japan Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 63. Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 69. India Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 71. India Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Obsessive-Compulsive Disorder Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Obsessive-Compulsive Disorder Treatment Market Share (2019-2020)
Table 75. Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Obsessive-Compulsive Disorder Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Obsessive-Compulsive Disorder Treatment Market Share by Application (2015-2020)
Table 79. AbbVie Inc. Company Details
Table 80. AbbVie Inc. Business Overview
Table 81. AbbVie Inc. Product
Table 82. AbbVie Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 83. AbbVie Inc. Recent Development
Table 84. Addex Therapeutics Ltd Company Details
Table 85. Addex Therapeutics Ltd Business Overview
Table 86. Addex Therapeutics Ltd Product
Table 87. Addex Therapeutics Ltd Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 88. Addex Therapeutics Ltd Recent Development
Table 89. C4X Discovery Limited Company Details
Table 90. C4X Discovery Limited Business Overview
Table 91. C4X Discovery Limited Product
Table 92. C4X Discovery Limited Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 93. C4X Discovery Limited Recent Development
Table 94. F. Hoffmann-La Roche Ltd. Company Details
Table 95. F. Hoffmann-La Roche Ltd. Business Overview
Table 96. F. Hoffmann-La Roche Ltd. Product
Table 97. F. Hoffmann-La Roche Ltd. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 98. F. Hoffmann-La Roche Ltd. Recent Development
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Product
Table 102. Novartis AG Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 103. Novartis AG Recent Development
Table 104. Omeros Corporation Company Details
Table 105. Omeros Corporation Business Overview
Table 106. Omeros Corporation Product
Table 107. Omeros Corporation Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 108. Omeros Corporation Recent Development
Table 109. Rottapharm SpA Company Details
Table 110. Rottapharm SpA Business Overview
Table 111. Rottapharm SpA Product
Table 112. Rottapharm SpA Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 113. Rottapharm SpA Recent Development
Table 114. Sellas Inc. Business Overview
Table 115. Sellas Inc. Product
Table 116. Sellas Inc. Company Details
Table 117. Sellas Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020) (Million US$)
Table 118. Sellas Inc. Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obsessive-Compulsive Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. ADX-88178 Features
Figure 3. Bitopertin Features
Figure 4. CR-5542 Features
Figure 5. Dipraglurant IR Features
Figure 6. Fluvoxamine Maleate Features
Figure 7. Mavoglurant Features
Figure 8. Others Features
Figure 9. Global Obsessive-Compulsive Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Research Center Case Studies
Figure 13. Obsessive-Compulsive Disorder Treatment Report Years Considered
Figure 14. Global Obsessive-Compulsive Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Obsessive-Compulsive Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Obsessive-Compulsive Disorder Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Obsessive-Compulsive Disorder Treatment Market Share by Players in 2019
Figure 19. Global Top Obsessive-Compulsive Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obsessive-Compulsive Disorder Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Obsessive-Compulsive Disorder Treatment Revenue in 2019
Figure 21. North America Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Obsessive-Compulsive Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed

以下、関連資料のご紹介

脂質異常症治療の世界市場（～2026年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12520 2020年11月25日 92Pages
当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

甲状腺障害治療の世界市場（～2026年）

Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04853 2020年11月20日 93Pages
当調査資料は甲状腺障害治療のグローバル市場について調査・分析したレポートです。種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

ENT疾患治療の世界市場（～2026年）

Global ENT Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11841 2020年11月25日 92Pages
当調査資料はENT疾患治療のグローバル市場について調査・分析したレポートです。種類別（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）市場規模、用途別（病院、クリニック、外来手術センター、在宅介護施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

季節性情動障害治療の世界市場（～2026年）

Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04565 2020年11月20日 90Pages
当調査資料は季節性情動障害治療のグローバル市場について調査・分析したレポートです。種類別（光線療法（光線療法）、薬物、心理療法、カウンセリング、その他）市場規模、用途別（病院、診療所、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）

Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY10928 2020年11月25日 94Pages
当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

認知症・運動障害治療の世界市場（～2026年）

Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11592 2020年11月25日 94Pages
当調査資料は認知症・運動障害治療のグローバル市場について調査・分析したレポートです。種類別（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）市場規模、用途別（ブランド薬品、ジェネリック薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年）

Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11930 2020年11月25日 97Pages
当調査資料は胎児性アルコールスペクトラム障害（FASD）治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

慢性うつ病性人格障害治療の世界市場（～2026年）

Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11360 2020年11月25日 96Pages
当調査資料は慢性うつ病性人格障害治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

色素沈着障害治療の世界市場（～2026年）

Global Pigmentation Disorder Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY04274 2020年11月20日 91Pages
当調査資料は色素沈着障害治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他））市場規模、用途別（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、...

睡眠障害治療薬の世界市場（～2026年）

Global Sleep Disorder Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04641 2020年11月20日 96Pages
当調査資料は睡眠障害治療薬のグローバル市場について調査・分析したレポートです。種類別（不眠症、過度睡眠、睡眠障害）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
ENT疾患治療の世界市場（～2026年） ENT is a medical abbreviation for ears, nose and throat. Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. Market Analysis and Insights: Global ENT Disorder Treatment Market The global ENT Disorder Treatment market size is projected to rea…
季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
自閉症スペクトラム障害（ASD）治療の世界市場（～2026年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…